NKF: Products exported to the U.S. are generic drugs, and the impact of tariffs needs further observation
On September 25th, local time, U.S. President Trump announced on his social media platform "Truth Social" that starting October 1st, the U.S. will impose a 100% tariff on patented and branded drugs. In response, the securities department of NKF told a reporter who called as an investor, "As of now, it should cover patented and original research drugs. We mainly deal in generic drugs, and we currently do not see any impact on us; we will need to further observe the official interpretation."
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments